Autonomix Medical, Inc. to Join Virtual Investor Webinar Organized by Ladenburg Thalmann & Co. Inc.

Written by Emily J. Thompson, Senior Investment Analyst

Source: Globenewswire

Updated: Aug 18 2025

0mins

Source: Globenewswire

Webinar Announcement: Autonomix Medical, Inc. will host a virtual investor webinar on August 21, 2025, at 1:00 PM ET, featuring CEO Brad Hauser and moderated by Jeffrey S. Cohen from Ladenburg Thalmann.
Company Focus: Autonomix is dedicated to advancing precision nerve-targeted treatments through innovative medical technologies, including a catheter-based microchip sensing array for diagnosing and treating nervous system diseases.
Initial Applications: The company's technology aims to address pain management, particularly in pancreatic cancer, and has potential applications across various medical fields such as cardiology and chronic pain management.
Regulatory Status: The technology is currently investigational and has not yet received marketing clearance in the United States.

About the author

Emily J. Thompson

Emily J. Thompson, a Chartered Financial Analyst (CFA) with 12 years in investment research, graduated with honors from the Wharton School. Specializing in industrial and technology stocks, she provides in-depth analysis for Intellectia’s earnings and market brief reports.

GET FREE REAL TIME NOTIFICATIONS

Stock Monitor for NVDA?

Get Started Free

FREE STOCK RECOMMENDATIONS DAILY

Stock Bullish Tomorrow

Get Started Free

70% BACKTESTED ACCURACY!

Should I Buy NVDA?

Get Started Free